Atai Life Sciences N.V. reported positive top-line phase 2a results of BPL-003 in treating Alcohol Use Disorder patients.

(NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced two ...

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...

Chinese actress Zhao Lusi has made her first public appearance following a month-long treatment for depression, capturing ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Men experience and express depression differently, often coping through unhealthy behaviors and resisting treatment due to ...

How can you make therapy work best for you? Here are a few tips. And a new study offers more evidence that teens are in trouble.

Baseline geriatric vulnerabilities and QOL scores are associated with survival after chemotherapy in older adults with metastatic pancreatic cancer, researchers found.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Scientists at Virginia Tech are revolutionizing depression treatment by tapping into how the brain processes rewards. Their ...

The treatment has become increasingly popular, especially among older men. Here is what to keep in mind if you are ...

Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...